Dr. Harinder Sandhu (PhD 1982): Dr. Sandhu has a brilliant thirty-five-year record of public service. He has been the face of Dental Education at Schulich Dentistry, Western University, both provincially and nationally, for over fifteen years. Dr. Sandhu has a unique quality of bringing divergent views together for the common good. As a prolific researcher, especially in the area of periodontics, Dr. Sandhu has received numerous academic awards and invitations to provide lectures on Periodontology worldwide. 

Dr. Peter Walker (MD 1972): Dr. Peter Walker is a former Professor and Dean of the Faculty of Medicine at the University of Ottawa. He was instrumental in constituting formal agreements between the Faculty and seven teaching hospitals, including the newly established Ottawa Hospital, the University of Ottawa Heart Institute, CHEO, Hôpital Montfort and the Royal Ottawa Health Care Group. As dean of the faculty between 1995-2006, student numbers in the MD Program increased from 84 to 152 students and graduate student numbers surged from 167 to 400.

Dr. Denis-Richard Roy (BA 1968, MD 1972, EMBA 1996): Dr. Denis-Richard Roy is an internationally recognized leader and physician specializing in nephrology. He was the President and CEO of Health Sciences North from 2009 up until his retirement in June 2017.  Under Roy's tenure, the former Sudbury Regional Hospital changed its name to "Health Sciences North," to reflect the hospital’s expanding role in research and medical training. He has been a member of several provincial, national and international boards including the Association of Canadian Academic Hospitals, Canadian Council on Health Services Accreditation and the Medical Research Council of Canada and served as Vice Chair of the Founding Board for the Canadian Patient Safety Institute. 

Dr. Valerie M. Weaver (PhD 1992): Dr. Valerie M. Weaver is the Director of the Center for Bioengineering and Tissue Regeneration and Professor in the Department of Surgery at the University of California (UFC) in San Francisco. She has been recognized for her research and leadership through prestigious awards including: the Colin Thomson Medal of Honor from the Worldwide Cancer Research, the National Cancer Institute Outstanding Investigator Award, and most recently the Biomedical Engineering Society Shu Chien Achievement Award in 2022. 

Dr. Siba Haykal Hunter (MD 2007 & BSc 2004): Dr. Siba Haykal Hunter is a Plastic and Reconstructive Surgeon and Assistant Professor of Surgery at the University Health Network.  Dr. Haykal has been the recipient of numerous grants and awards for her clinical, academic and research work including a CIHR Vanier Scholarship. In 2021, she was named as an honoree of Canada’s Top 40 under 40 award which recognizes Canadian leaders who inspire others, are visionaries and creative problem solvers, and give back to communities. 

Julie J. Burtt (Spéc./Hon.; BSc, Physiology 2007):  Mrs. Julie J. Burtt is a Radiation and Health Sciences Specialist at the Canadian Nuclear Safety Commission (CNSC). She received a Bachelor of Science in Physiology with Honors in 2007 from the University of Ottawa. Mrs. Burtt has over 15 years of experience in the field of radiation biology with primary area of research being human health impacts from exposures to low doses of ionizing radiation. She is also a member of the National Energy Agency’s Expert Group on Non-Radiological Public Health Aspects of Radiation Emergency Planning and Response and a scientific committee member with the Canadian Organization on Health Effects from Radiation Exposure. In her spare time, Mrs. Burtt is actively pursuing her PhD in Human Studies and Interdisciplinarity at Laurentian University.

Dr. Ali Azizi is an immunologist who specialize in the field of vaccinology. He has over 20 years of experience in large pharma, biotech, and academia and collaborated with several partners and international organizations on various vaccine trials performed in North America and overseas. In his role at Sanofi Pasture, Ali has led, managed, and contributed to several global vaccine projects from pre-clinical to end of phase III trial (e.g. COVID-19, HIV-1, HSV-II, MenB, Influenza, etc.) for over a decade. In August, he joined Health Canada, where he is now reviewing vaccine submissions and working closely with international organizations including the World Health Organization.

Dr. Noni MacDonald is a professor of Pediatrics (Infectious Diseases) at Dalhousie University and the IWK Health Centre in Halifax, Canada. Two of her major areas of interest are vaccines and microresearch. She has been a member of the Strategic Advisory Group of Experts on immunization for the World Health Organization (SAGE) since 2017. She has published over 450 papers and has long been recognized in Canada and internationally as an advocate for children and youth health and as a leader in pediatric infectious disease and global health. She is an elected Fellow of the Canadian Academy of Health Sciences and of the Royal Society of Canada. She is an Officer of the Order of Canada and a recipient of the Order of Nova Scotia.

Dr. Michael Fraser completed his PhD. degree in Dr. Benjamin Tsang’s laboratory (Cellular and Molecular Medicine), followed by post-doctoral training in radiation medicine, radiobiology, and prostate cancer genomics at the Princess Margaret Cancer Centre in Toronto. He previously served as scientific director of the Canadian Prostate Cancer Genome Network (CPC-GENE) program, where he co-led seminal studies into the genomic, transcriptomic, and epigenomic landscapes of localized prostate cancer. Michael has authored 55 research papers in top tier international journals, and holds multiple patents related to biomarkers for improving treatment of localized prostate cancer. In 2021, Michael was appointed the inaugural director, implementation – Cancer at Movember Canada.

Dr. Naveed Mohammad is currently president and CEO of William Osler Health System (Osler). Osler is one of Canada’s largest community hospital systems, serving 1.3 million people who live in a fast-growing and culturally-diverse region of the Greater Toronto Area. 
Dr. Mohammad joined Osler in 1997 as an emergency physician at Etobicoke General and has held a number of physician leadership  roles of increasing responsibility including being named Etobicoke General Site Chief,  Emergency Medicine in 2001 and Chief Emergency Services in 2006. As a senior leader, a physician, a donor, and a community member, Dr. Mohammad is passionately invested in ensuring quality health care services.

Dr Denise Werker is a public health and preventive medicine specialist and clinical associate professor, Department of Community Health and Epidemiology, College of Medicine, University of Saskatchewan. She has assisted the Saskatchewan Ministry of Health with the public health response to the COVID-19 pandemic. Her public health practice spans all levels of government in Canada and international governmental organizations. She has practiced as a family doctor in rural and urban communities in British Columbia and served on various committees and boards of professional and non-profit organizations.

Dr. Guy Rouleau is the director of the Montreal Neurological Institute‐Hospital (The Neuro), chair of the Department of Neurology and Neurosurgery of McGill University, director of the Department of Neuroscience of McGill University Health Centre (MUHC), and co‐founder of the Tanenbaum Open Science Institute.

Dr. Rouleau has contributed to the identification of more than 20 disease-causing genes and discovered new mutational mechanisms. He has published more than 850 articles in top peer-reviewed journals as well as 50 review articles and book chapters. His work has been cited over 30,000 times. He has delivered more than 150 lectures around the world.

Dr. Rafal Iwasiow is currently the vice-president, Innovation and Technology, at OraSure Technologies. OraSure is a leader in the development and distribution of point-of-care diagnostic tests, molecular collection devices and other technologies designed to detect or diagnose critical medical conditions. Prior to this, Dr. Iwasiow worked as vice-president, Research and Development, at DNA Genotek. In 2008 he took on the responsibility of managing the product development team and has advanced his career through director level roles to his appointment as vice-president of Research and Development. Under Dr. Iwasiow's leadership, the research and development team contributed to successful 510(k) clearances of the Oragene-Dx collection device, the first non-invasive DNA collection device cleared by the FDA.

Dr. James Makokis is a Cree from the Saddle Lake First Nation in Northern Alberta. As a doctor, national presenter, and proud member of the LGBTQI2S+ and First Nation communities, Dr. Makokis' strong connections to preventative health, spirituality, and two-spirit identity have helped save lives within the LGBTQI2S+ and First Nation communities. As the leader of one of North America's most progressive and successful transgender focused medical practices, Dr. Makokis facilitates the wellness of transgender people through hormone replacement therapy. Dr. Makokis currently serves on several boards including the Waakebiness-Bryce Institute for Indigenous Health at the University of Toronto, and McEwan University's Indigenous Advisory Council. Dr. Makokis and partner Anthony Johnson were recently crowned Season 7 winners of the Amazing Race Canada.

Dr. Ashnoor Nagji is a family physician who has provided international medical care to some of the world's most marginalized populations. She has traveled to over 80 countries and has treated patients in places including Afghanistan, Tanzania, India, and Pakistan. Dr. Nagji believes that connecting with patients is what helps a physician hone critical skills and recognizes the importance of considering a patient's background. Recently her work has been recognized with the Ontario Medical Association's Glenn Sawyer Award for Community Service.